Tag: Parkinson’s

EVER Pharma launches patient friendly subcutaneous pump for Parkinson’s disease

EVER Pharma, a company specialising in neurological diseases, announces the launch of its D-mine  Pump. This portable micro infusion device recently received European CE...

New data show the therapeutic benefits of directional leads for use...

The PROGRESS study has achieved its primary endpoint and demonstrated superiority of the therapeutic window using Abbott directional stimulation compared to omnidirectional stimulation. Results...

DBS treatment may slow the progression of parkinson’s tremor in early-stage...

A study at Vanderbilt University Medical Centre, Nashville, USA has provided the first evidence of a treatment that slows the progression of one of...

Self-tuning brain implant could help treat patients with Parkinson’s disease

This study describes the first fully implanted DBS system that uses feedback from the brain itself to fine-tune its signalling. The study was supported...

Positive late-breaking data from the INTREPID study announced

The one-year data from the INTREPID study, the first and only prospective, double-blind, randomised, sham-controlled, multi-centre study of deep brain stimulation (DBS) for advanced,...

FDA approves safinamide to treat Parkinson’s disease

The US Food and Drug Administration (FDA) has approved safinamide (Xadago) tablets as an add-on treatment for patients with Parkinson's disease who are currently...